A detailed history of Black Rock Inc. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Black Rock Inc. holds 16,826,081 shares of CORT stock, worth $508 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
16,826,081
Previous 16,407,696 2.55%
Holding current value
$508 Million
Previous $533 Million 20.47%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$21.1 - $27.46 $8.83 Million - $11.5 Million
418,385 Added 2.55%
16,826,081 $424 Million
Q4 2023

Feb 13, 2024

BUY
$24.82 - $32.88 $30 Million - $39.8 Million
1,210,549 Added 7.97%
16,407,696 $533 Million
Q3 2023

Nov 13, 2023

SELL
$21.97 - $33.8 $2.01 Million - $3.1 Million
-91,635 Reduced 0.6%
15,197,147 $414 Million
Q2 2023

Aug 11, 2023

SELL
$21.44 - $25.15 $18 Million - $21.1 Million
-840,033 Reduced 5.21%
15,288,782 $340 Million
Q1 2023

May 12, 2023

SELL
$19.2 - $24.47 $4.2 Million - $5.35 Million
-218,568 Reduced 1.34%
16,128,815 $349 Million
Q4 2022

Feb 13, 2023

BUY
$19.95 - $29.96 $3.2 Million - $4.8 Million
160,334 Added 0.99%
16,347,383 $332 Million
Q3 2022

Nov 14, 2022

BUY
$24.7 - $29.12 $17.8 Million - $20.9 Million
719,416 Added 4.65%
16,187,049 $415 Million
Q2 2022

Aug 12, 2022

BUY
$17.33 - $25.3 $742,867 - $1.08 Million
42,866 Added 0.28%
15,467,633 $368 Million
Q1 2022

May 12, 2022

BUY
$16.53 - $25.21 $6.23 Million - $9.5 Million
376,774 Added 2.5%
15,424,767 $347 Million
Q4 2021

Feb 10, 2022

SELL
$17.1 - $23.34 $9.33 Million - $12.7 Million
-545,883 Reduced 3.5%
15,047,993 $298 Million
Q3 2021

Nov 09, 2021

SELL
$19.68 - $22.53 $524,314 - $600,244
-26,642 Reduced 0.17%
15,593,876 $307 Million
Q2 2021

Aug 11, 2021

BUY
$19.97 - $24.43 $312 Million - $382 Million
15,620,518 New
15,620,518 $344 Million

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $3.23B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.